Biotech ETFs Sholud Like AbbVie’s bid for Pharmacyclics
March 05, 2015 at 07:30 AM EST
Shares of Pharmacyclics (NasdaqGS: PCYC), a maker of cancer treatments, rose more than 2% during Wednesday’s after-hours session following a 6.3% surge on almost two and a half times the average voile during tradition trading hours on reports Dow component Johnson & Johnson (NYSE: JNJ) was...